Journal
BIOENGINEERED
Volume 13, Issue 5, Pages 12298-12308Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2022.2071022
Keywords
glycolysis; osteosarcoma; AKT; mTOR
Categories
Ask authors/readers for more resources
This study revealed that S100A10 is highly expressed in osteosarcoma tissues and cell lines. It promotes proliferation and metastasis while inhibiting apoptosis in osteosarcoma cells. S100A10 regulates the glycolysis process and activates the AKT/mTOR signaling pathway, thereby promoting malignant behavior in osteosarcoma cells.
As an aggressive musculoskeletal malignancy, osteosarcoma (OSa) is popular among young adults and teenagers worldwide. S100 calcium-binding protein A10 (S100A10) functioned as a novel tumor-promoting protein in several human cancers. However, its role in OSa remains obscure. In this study, gene and protein levels were respectively determined by RT-qPCR or Western blotting. OSa cell proliferation, apoptosis, and metastasis were evaluated via CCK-8, colony formation, flow cytometry, and Transwell assays. To assess the glycolysis level, glucose consumption and lactate production were detected. It was found S100A10 was highly expressed in OSa tissues and cell lines. Besides, S100A10 facilitated proliferation and metastasis, and inhibited apoptosis in OSa cells. In addition, S100A10 regulated OSa cell proliferation, metastasis and apoptosis via mediating the glycolysis process. Furthermore, S100A10-mediated AKT/mTOR signaling accelerated glycolysis, thereby promoting malignant behaviors in OSa cells. Taken together, our findings indicated that S100A10 might promote malignant phenotypes of OSa cells by accelerating glycolysis and activating the AKT/mTOR signaling, providing a promising target for OSa treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available